Rheumatoid Arthritis Posts - Page 22 of 35 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Should methotrexate dosage be reduced when prescribed with adalimumab for RA patients?

Should methotrexate dosage be reduced when prescribed with adalimumab for RA patients?

Posted by on Aug 1, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the outcomes of reducing the dosage of methotrexate (Rheumatrex) when it is combined with adalimumab (Humira) in the treatment of rheumatoid arthritis (RA). The study found that a higher dose of methotrexate lead to a greater decrease in disease activity. Reduction of methotrexate dosage is not supported by these...

Read More

Do biological drug treatments for rheumatoid arthritis increase the risk of skin cancer?

Posted by on Jul 25, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell The study looked at the association between biological drug treatment for rheumatoid arthritis (RA) and the risk of melanoma (skin cancer). The authors concluded that there was no increased risk of melanoma in RA patients receiving treatment with biologics.   Some background In RA, the immune system attacks the healthy joints...

Read More

Long-term effects of adalimumab in patients with rheumatoid arthritis

Posted by on Jul 3, 2016 in Rheumatoid Arthritis | 1 comment

In a nutshell The study looked at the long-term risks associated with adalimumab (Humira) in patients with rheumatoid arthritis. The authors concluded that no additional long-term risks related to serious infections, response to vaccines or birth defects have been found. Some background In rheumatoid arthritis (RA), the immune system attacks the...

Read More

Can an immune response to certolizumab pegol reduce its effectiveness?

Can an immune response to certolizumab pegol reduce its effectiveness?

Posted by on Jun 20, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell The study looked at the immune response of patients with rheumatoid arthritis to certolizumab pegol (Cimzia) and the effect this has on response to the drug. The authors concluded that patients who develop an immune response to certolizumab pegol have lower levels of the drug in their system after 12 months, and that higher levels...

Read More

Is tofacitinib an effective treatment for early stage rheumatoid arthritis?

Is tofacitinib an effective treatment for early stage rheumatoid arthritis?

Posted by on Jun 18, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined how effective tofacitinib (Xeljanz) is as a treatment for early stage rheumatoid arthritis. The authors concluded that tofacitinib treatment on its own or in conjunction with methotrexate (Trexall) can reduce inflammation and can slow disease progression.  Some background Patients with rheumatoid arthritis...

Read More

The effects of smoking on mortality rates in patients with rheumatoid arthritis

Posted by on Jun 13, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of smoking on mortality rates in patients with rheumatoid arthritis (RA). The authors concluded that overall mortality and cardiovascular and lung cancer mortality rates were higher in current smokers compared to non-smokers.  Some background Smoking is a known risk factor for rheumatoid...

Read More

Can treatments for rheumatoid arthritis decrease responses to vaccinations?

Can treatments for rheumatoid arthritis decrease responses to vaccinations?

Posted by on Jun 3, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of rheumatoid arthritis (RA) treatments on patient reponses to influenza and pneumococcal vaccinations. The treatments included in this study were methotrexate (Rheumatrex), rituximab (Rituxan) and anti-tumor necrosis factor alpha (TNFa) drugs. Methotrexate and rituximab decreased patient responses to both...

Read More

Patient preferences when choosing biological treatments for rheumatoid arthritis

Patient preferences when choosing biological treatments for rheumatoid arthritis

Posted by on May 30, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at rheumatoid arthritis (RA) patients’ preferences when choosing either an infused or an injected biological treatment. It also compared patient reported outcomes (PRO) for treatment with adalimumab (Humira) and etanercept (Enbrel). Some background Biological drugs are becoming a common treatment for RA. These...

Read More

Treatment of early stage rheumatoid arthritis with a combination of drugs

Treatment of early stage rheumatoid arthritis with a combination of drugs

Posted by on May 21, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effectiveness of a combination of certolizumab pegol (Cimzia) and methotrexate (Rheumatrex) in treating early stage rheumatoid arthritis (RA). The authors concluded that this combination of drugs was considerably effective in RA patients. Some background In RA, the immune system attacks the healthy...

Read More